🇺🇸 FDA
Patent

US 9206154

Inverse agonists and neutral antagonists for the TSH receptor

granted A61KA61K31/517A61P

Quick answer

US patent 9206154 (Inverse agonists and neutral antagonists for the TSH receptor) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61K, A61K31/517, A61P, A61P27/02, A61P35/00